Trial Details

COMPLETED
Basic Information
Clinical ID c4169
Identifier NCT00945334
Trial Title Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Constipation-predominant Irritable Bowel Syndrome
Interventions DRUG: Neomycin|DRUG: Placebo|DRUG: Rifaximin
Participant Information
Sponsor Mark Pimentel, MD
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2009-08
Primary Completion Date 2013-06
Completion Date 2013-06